...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: ESC Poster on BETonMACE Design and Baseline Data

The first of two ESC 2019 posters is now up and can be accessed here. "BET-inhibition with Apabetalone in Post-ACS Patients with Diabetes: Design and Baseline Characteristics of the BETonMACE Trial"

https://www.resverlogix.com/upload/media_element/177/76b2a9c98699/2019-09-02-esc-design-poster-final.pdf

Nothing new that we didn't see in previous BETonMACE design/baseline posters and/or the recently published paper.

https://www.sciencedirect.com/science/article/abs/pii/S0002870319301978

BearDownAZ

Share
New Message
Please login to post a reply